Anticoagulation in percutaneous coronary interventions: no man's land?
نویسندگان
چکیده
منابع مشابه
Anticoagulation in percutaneous coronary interventions: no man's land?
Since the first days of percutaneous coronary interventions (PCI), it has been a common understanding to treat patients with a combination of antiplatelet and anticoagulant drugs to prevent thrombotic complications. Numerous anticoagulants have been tested during elective PCI. Nonetheless, aspirin and unfractionated heparin (UFH) have survived more than 30 years as the standard regimen, particu...
متن کاملAnticoagulation in percutaneous coronary intervention
Balancing safety and efficacy of anticoagulation strategies is a fundamental goal in the performance of percutaneous coronary interventions. The ideal anticoagulant in the catheterization laboratory should effectively prevent thrombosis, yield a low bleeding risk, be titratable to individual clinical needs, be reversible when clinically indicated and be administered without the need for complic...
متن کاملStroke after percutaneous coronary interventions.
n this issue of the Journal, Dukkipati et al. (1) identified the ncidence, predictors, and outcomes of stroke in patients ndergoing percutaneous coronary interventions (PCIs). troke occurred in hospital in 92 of 20,670 patients (0.3%) fter PCI, which is higher than the reported rates of 0.08% o 0.17% after diagnostic catheterization (2). The good news in this report is that brain injury hapened...
متن کاملThe Rise and Fall of Anticoagulation with Bivalirudin During Percutaneous Coronary Interventions: A Review Article
Bivalirudin is a direct thrombin inhibitor used during percutaneous coronary intervention (PCI). Treatment with bivalirudin compared to heparin plus glycoprotein IIb/IIIa inhibitors (GPI) reduced bleeding complications, but resulted in higher rates of ischemic events, including acute stent thrombosis in ST segment elevation myocardial infarction (STEMI) patients. Thus, it may be considered a re...
متن کاملantiplatelet therapy in hemodialysis patients undergoing percutaneous coronary interventions
conclusions this investigation might contribute to delineate the best treatment options for this high risk population. evidence acquisition we reviewed current evidences on the use of antiplatelet therapy in patients with esrd/hd undergoing pci, focusing on the efficacy and safety of specific agents and their indications for detailed clinical settings. results clinical setting in hd patients is...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2010
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehq344